Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


13.02.2017

1 Am J Clin Nutr
1 Ann Intern Med
1 BMC Ophthalmol
2 BMJ
7 Diabet Med
1 Diabetes Care
1 Diabetes Educ
4 Diabetes Obes Metab
1 Diabetologia
4 Eur J Endocrinol
1 J Am Soc Nephrol
1 J Biol Chem
8 J Diabetes Complications
1 J Hypertens
2 JAMA
1 Kidney Int
1 Lancet Diabetes Endocrinol
1 Nutr Metab (Lond)
1 Ophthalmology
2 Pediatr Diabetes
8 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Nutr

  1. ALPERET DJ, Butler LM, Koh WP, Yuan JM, et al
    Influence of temperate, subtropical, and tropical fruit consumption on risk of type 2 diabetes in an Asian population.
    Am J Clin Nutr. 2017 Feb 8. pii: ajcn147090. doi: 10.3945/ajcn.116.147090.
    PubMed     Text format     Abstract available


    Ann Intern Med


  2. Correction: Do Sugar-Sweetened Beverages Cause Obesity and Diabetes?
    Ann Intern Med. 2017;166:232.
    PubMed     Text format    


    BMC Ophthalmol

  3. BUHLER AD, Bucher F, Augustynik M, Wohrl J, et al
    Systemic confounders affecting serum measurements of omega-3 and -6 polyunsaturated fatty acids in patients with retinal disease.
    BMC Ophthalmol. 2016;16:159.
    PubMed     Text format     Abstract available


    BMJ

  4. ADAM S, Ammori B, Soran H, Syed AA, et al
    Pregnancy after bariatric surgery: screening for gestational diabetes.
    BMJ. 2017;356:j533.
    PubMed     Text format    

  5. MAYOR S
    Preventing weight gain in all adults may cut diabetes by a fifth, study shows.
    BMJ. 2017;356:j653.
    PubMed     Text format    


    Diabet Med

  6. CLARKE AB, Daneman D, Curtis JR, Mahmud FH, et al
    Impact of neighbourhood-level inequity on paediatric diabetes care.
    Diabet Med. 2017 Feb 6. doi: 10.1111/dme.13326.
    PubMed     Text format     Abstract available

  7. OKA R, Aizawa T, Yoneda T, Yamagishi M, et al
    Reply to Kawada One-hour plasma glucose as a predictor of Type 2 diabetes mellitus.
    Diabet Med. 2017 Feb 7. doi: 10.1111/dme.13329.
    PubMed     Text format     Abstract available

  8. DAY JO, Flanagan SE, Shepherd MH, Patrick AW, et al
    Hyperglycaemia-related complications at the time of diagnosis can cause permanent neurological disability in children with neonatal diabetes.
    Diabet Med. 2017 Feb 7. doi: 10.1111/dme.13328.
    PubMed     Text format     Abstract available

  9. KAWADA T
    One-hour plasma glucose as a predictor of Type 2 diabetes mellitus.
    Diabet Med. 2017 Feb 7. doi: 10.1111/dme.13330.
    PubMed     Text format     Abstract available

  10. BASKERVILLE R, Ricci-Cabello I, Roberts N, Farmer A, et al
    Impact of accelerometer and pedometer use on physical activity and glycaemic control in people with Type 2 diabetes: a systematic review and meta-analysis.
    Diabet Med. 2017 Feb 7. doi: 10.1111/dme.13331.
    PubMed     Text format     Abstract available

  11. HOLDEN SE, Jenkins-Jones S, Morgan CL, Peters JR, et al
    Prevalence, glucose control and relative survival of people with Type 2 diabetes in the UK from 1991 to 2013.
    Diabet Med. 2017 Feb 7. doi: 10.1111/dme.13332.
    PubMed     Text format     Abstract available

  12. KOYE DN, Shaw JE, Reid CM, Atkins RC, et al
    Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies.
    Diabet Med. 2017 Feb 6. doi: 10.1111/dme.13324.
    PubMed     Text format     Abstract available


    Diabetes Care

  13. ACEVEDO-CALADO M, James EA, Morran MP, Pietropaolo SL, et al
    Identification of Unique Antigenic Determinants in the Amino Terminus of IA-2 (ICA512) in Childhood and Adult Autoimmune Diabetes: New Biomarker Development.
    Diabetes Care. 2017 Feb 7. pii: dc161527. doi: 10.2337/dc16-1527.
    PubMed     Text format     Abstract available


    Diabetes Educ

  14. SANDBERG J, Yorgason JB, Fisher L, Weinstock RS, et al
    Does Length of Relationship or Gender Predict Response to Behavioral Diabetes Intervention?
    Diabetes Educ. 2017 Feb 1:145721717691147. doi: 10.1177/0145721717691147.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  15. ALATORRE C, Fernandez Lando L, Yu M, Brown K, et al
    Treatment Patterns in Patients with Type 2 Diabetes Mellitus Treated with GLP-1 Receptor Agonists: Higher Adherence and Persistence with Dulaglutide Compared to Exenatide QW and Liraglutide.
    Diabetes Obes Metab. 2017 Feb 9. doi: 10.1111/dom.12902.
    PubMed     Text format     Abstract available

  16. KRAMER CK, Zinman B, Choi H, Connelly PW, et al
    Chronic liraglutide therapy induces an enhanced endogenous glucagon-like peptide-1 secretory response in early type 2 diabetes.
    Diabetes Obes Metab. 2017 Feb 9. doi: 10.1111/dom.12858.
    PubMed     Text format     Abstract available

  17. KADOWAKI T, Inagaki N, Kondo K, Nishimura K, et al
    Efficacy and safety of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: results of a 24-week, randomised, double-blind, placebo-controlled trial.
    Diabetes Obes Metab. 2017 Feb 8. doi: 10.1111/dom.12898.
    PubMed     Text format     Abstract available

  18. SUCHER S, Markova M, Hornemann S, Pivovarova O, et al
    A comparison of the effects of diets high in animal or plant protein on metabolic and cardiovascular markers in type 2 diabetes - a randomized clinical trial.
    Diabetes Obes Metab. 2017 Feb 9. doi: 10.1111/dom.12901.
    PubMed     Text format     Abstract available


    Diabetologia

  19. MCCARTHY MI
    Painting a new picture of personalised medicine for diabetes.
    Diabetologia. 2017 Feb 7. doi: 10.1007/s00125-017-4210.
    PubMed     Text format     Abstract available


    Eur J Endocrinol

  20. BREUER TG, Borker L, Quast DR, Tannapfel A, et al
    Impact of proton pump inhibitor treatment on pancreatic beta-cell area and beta-cell proliferation in humans.
    Eur J Endocrinol. 2016;175:467-76.
    PubMed     Text format     Abstract available

  21. LESEN E, Granfeldt D, Houchard A, Dinet J, et al
    Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study.
    Eur J Endocrinol. 2017;176:203-212.
    PubMed     Text format     Abstract available

  22. HJORTEBJERG R, Laugesen E, Hoyem P, Oxvig C, et al
    The IGF system in patients with type 2 diabetes: associations with markers of cardiovascular target organ damage.
    Eur J Endocrinol. 2017 Feb 8. pii: EJE-16-0940. doi: 10.1530/EJE-16-0940.
    PubMed     Text format     Abstract available

  23. SARDELLA C, Cappellani D, Urbani C, Manetti L, et al
    Disease activity and lifestyle influence comorbidities and cardiovascular events in patients with acromegaly.
    Eur J Endocrinol. 2016;175:443-53.
    PubMed     Text format     Abstract available


    J Am Soc Nephrol

  24. VAN JA, Scholey JW, Konvalinka A
    Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics.
    J Am Soc Nephrol. 2017 Feb 3. pii: ASN.2016091018. doi: 10.1681/ASN.2016091018.
    PubMed     Text format     Abstract available


    J Biol Chem

  25. VADVALKAR SS, Matsuzaki S, Eyster CA, Giorgione JR, et al
    Decreased Mitochondrial Pyruvate Transport Activity in the Diabetic Heart: Role of MPC2 Acetylation.
    J Biol Chem. 2017 Feb 1. pii: jbc.M116.753509. doi: 10.1074/jbc.M116.753509.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  26. RATHMANN W, Kostev K
    Association of dipeptidyl peptidase 4 inhibitors with risk of metastases in patients with type 2 diabetes and breast, prostate or digestive system cancer.
    J Diabetes Complications. 2017 Jan 26. pii: S1056-8727(16)31034.
    PubMed     Text format     Abstract available

  27. SHEHATA MM, Kamal MM, El-Hefnawy MH, El-Mesallamy HO, et al
    Association of serum pancreatic derived factor (PANDER) with beta-cell dysfunction in type 2 diabetes mellitus.
    J Diabetes Complications. 2017 Jan 20. pii: S1056-8727(16)30490.
    PubMed     Text format     Abstract available

  28. YOKOTA N, Miyakoshi T, Sato Y, Nakasone Y, et al
    Predictive models for conversion of prediabetes to diabetes.
    J Diabetes Complications. 2017 Jan 20. pii: S1056-8727(16)30939.
    PubMed     Text format     Abstract available

  29. GILBERT RE
    Finerenone in diabetic kidney disease - So far, so good.
    J Diabetes Complications. 2017 Jan 20. pii: S1056-8727(16)31090.
    PubMed     Text format    

  30. BARSHES NR, Saedi S, Wrobel J, Kougias P, et al
    A model to estimate cost-savings in diabetic foot ulcer prevention efforts.
    J Diabetes Complications. 2017 Jan 21. pii: S1056-8727(16)30414.
    PubMed     Text format     Abstract available

  31. GIBBONS CH
    Treatment induced neuropathy of diabetes-Long term implications in type 1 diabetes.
    J Diabetes Complications. 2017 Jan 21. pii: S1056-8727(16)30631.
    PubMed     Text format     Abstract available

  32. PETRICA L, Vlad M, Vlad A, Gluhovschi G, et al
    Podocyturia parallels proximal tubule dysfunction in type 2 diabetes mellitus patients independently of albuminuria and renal function decline: A cross-sectional study.
    J Diabetes Complications. 2017 Jan 20. pii: S1056-8727(16)30753.
    PubMed     Text format     Abstract available

  33. GOINS RT, Noonan C, Gonzales K, Winchester B, et al
    Association of depressive symptomology and psychological trauma with diabetes control among older American Indian women: Does social support matter?
    J Diabetes Complications. 2017 Jan 20. pii: S1056-8727(16)30610.
    PubMed     Text format     Abstract available


    J Hypertens

  34. ATKINS ER, Hirakawa Y, Salam A, Woodward M, et al
    Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the perindopril protection against recurrent stroke study and action in diabetes and vascular disease: preterax and diamicron-MR co
    J Hypertens. 2017 Feb 6. doi: 10.1097/HJH.0000000000001287.
    PubMed     Text format     Abstract available


    JAMA

  35. HAMPTON T
    Drug Under Study for Diabetes a Potential Parkinson Therapy.
    JAMA. 2017;317:465.
    PubMed     Text format    

  36. XIANG AH
    Association of Maternal Diabetes With Autism in Offspring.
    JAMA. 2017;317:537-538.
    PubMed     Text format    


    Kidney Int

  37. KLEMIS V, Ghura H, Federico G, Wurfel C, et al
    Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes.
    Kidney Int. 2017 Jan 31. pii: S0085-2538(16)30706.
    PubMed     Text format     Abstract available


    Lancet Diabetes Endocrinol

  38. NILSSON PM, Kjeldsen SE
    Blood pressure goals in type 2 diabetes-assessing the evidence.
    Lancet Diabetes Endocrinol. 2017 Feb 3. pii: S2213-8587(17)30035.
    PubMed     Text format    


    Nutr Metab (Lond)

  39. OSHAKBAYEV K, Dukenbayeva B, Togizbayeva G, Durmanova A, et al
    Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial.
    Nutr Metab (Lond). 2017;14:11.
    PubMed     Text format     Abstract available


    Ophthalmology

  40. BRESSLER SB, Beaulieu WT, Glassman AR, Gross JG, et al
    Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Ophthalmology. 2017 Feb 1. pii: S0161-6420(16)31179.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  41. FATH M, Danne T, Biester T, Erichsen L, et al
    Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus.
    Pediatr Diabetes. 2017 Feb 6. doi: 10.1111/pedi.12506.
    PubMed     Text format     Abstract available

  42. WEISSBERG-BENCHELL J, Rychlik K
    Diabetes camp matters: Assessing families' views of their diabetes camp experience.
    Pediatr Diabetes. 2017 Feb 3. doi: 10.1111/pedi.12499.
    PubMed     Text format     Abstract available


    PLoS One

  43. ZHAO H, Li X, Zhao T, Zhang H, et al
    Tangshen formula attenuates diabetic renal injuries by upregulating autophagy via inhibition of PLZF expression.
    PLoS One. 2017;12:e0171475.
    PubMed     Text format     Abstract available

  44. CHEN YW, Wang JS, Sheu WH, Lin SY, et al
    Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.
    PLoS One. 2017;12:e0171753.
    PubMed     Text format     Abstract available

  45. LI Q, Wang Y, Ma T, Lv Y, et al
    Clinical outcomes of patients with and without diabetes mellitus after hepatectomy: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0171129.
    PubMed     Text format     Abstract available

  46. KIM SS, Shin N, Bae SS, Lee MY, et al
    Enhanced expression of two discrete isoforms of matrix metalloproteinase-2 in experimental and human diabetic nephropathy.
    PLoS One. 2017;12:e0171625.
    PubMed     Text format     Abstract available

  47. VIJAYAKUMAR P, Hoyer A, Nelson RG, Brinks R, et al
    Estimation of chronic kidney disease incidence from prevalence and mortality data in American Indians with type 2 diabetes.
    PLoS One. 2017;12:e0171027.
    PubMed     Text format     Abstract available

  48. LV X, Qiao W, Leng Y, Wu L, et al
    Impact of diabetes mellitus on clinical outcomes of pancreatic cancer after surgical resection: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0171370.
    PubMed     Text format     Abstract available

  49. SUNG JY, Tani J, Chang TS, Lin CS, et al
    Uncovering sensory axonal dysfunction in asymptomatic type 2 diabetic neuropathy.
    PLoS One. 2017;12:e0171223.
    PubMed     Text format     Abstract available

  50. ABDOLLAHI M, Ng TS, Rezaeizadeh A, Aamidor S, et al
    Insulin treatment prevents wounding associated changes in tissue and circulating neutrophil MMP-9 and NGAL in diabetic rats.
    PLoS One. 2017;12:e0170951.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: